Skip to Content


In the US, Surfaxin (lucinactant systemic) is a member of the drug class lung surfactants and is used to treat Respiratory Distress Syndrome.

US matches:

Ingredient matches for Surfaxin


Lucinactant is reported as an ingredient of Surfaxin in the following countries:

  • United States

← International Drug Name Search

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.